| Views | |
|---|---|
| Efficacy of Sym004 in Patients With Metastatic Colorectal Cancer With Acquired Resistance to Anti-EGFR Therapy and Molecularly Selected by Circulating Tumor DNA Analyses: A Phase 2 Randomized Clinical Trial | 52 |
| January 2024 | February 2024 | March 2024 | April 2024 | May 2024 | June 2024 | July 2024 | |
|---|---|---|---|---|---|---|---|
| Efficacy of Sym004 in Patients With Metastatic Colorectal Cancer With Acquired Resistance to Anti-EGFR Therapy and Molecularly Selected by Circulating Tumor DNA Analyses: A Phase 2 Randomized Clinical Trial | 0 | 17 | 0 | 7 | 5 | 13 | 10 |
| Views | |
|---|---|
| artconlli_a2018_tabernero_josep_efficacy_Sym004.pdf | 7 |
| Views | |
|---|---|
| United States | 34 |
| China | 7 |
| Canada | 2 |
| Spain | 1 |
| Views | |
|---|---|
| Menlo Park | 24 |
| Shanghai | 6 |
| Oakland | 5 |
| San Diego | 4 |
| Ottawa | 2 |
| Barcelona | 1 |
| Guangzhou | 1 |
| Jackson | 1 |